Previous reports studying p53 and its main target p21Cip1, which were involved in the activation of cyclin-dependent kinase inhibitors (CDKIs) to induce permanent cell cycle arrest, were the main focus of extensive research leading to the recognition of senescence in cancer. Here, CDKN1A is linked to cancer.